Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
B 9.38 1.96% 0.18
BHC closed up 1.96 percent on Monday, March 18, 2024, on 51 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Gapped Up Strength 0.00%
Crossed Above 20 DMA Bullish 1.96%
Inside Day Range Contraction 1.96%
Fell Below 20 DMA Bearish 3.19%
Gapped Down Weakness 3.19%
Shooting Star Candlestick Bearish 1.08%
20 DMA Support Bullish 2.07%
NR7 Range Contraction 2.07%
NR7-2 Range Contraction 2.07%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 11 hours ago
Up 2% about 11 hours ago
Up 1% about 16 hours ago
20 DMA Support about 16 hours ago
10 DMA Support about 16 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bausch Health Companies Inc. Description

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Life Sciences Organ Systems Laser Eye Pharmaceutical Products Gastrointestinal Medical Device S&P/Tsx 60 Index Health Products Dermatology Psoriasis Specialty Drugs Gastroenterology Ulcerative Colitis Ulcer Colitis Atopic Dermatitis Acne Dermatitis Diarrhea Contact Lens Irritable Bowel Syndrome Generic Pharmaceutical Wrinkle Generic Pharmaceuticals Hair Removal Over The Counter Products Actinic Keratosis Keratosis

Is BHC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.145
52 Week Low 5.5703
Average Volume 2,364,800
200-Day Moving Average 8.07
50-Day Moving Average 8.63
20-Day Moving Average 9.23
10-Day Moving Average 9.26
Average True Range 0.28
RSI (14) 59.68
ADX 34.6
+DI 29.65
-DI 14.95
Chandelier Exit (Long, 3 ATRs) 9.05
Chandelier Exit (Short, 3 ATRs) 9.16
Upper Bollinger Bands 9.78
Lower Bollinger Band 8.67
Percent B (%b) 0.64
BandWidth 12.00
MACD Line 0.20
MACD Signal Line 0.25
MACD Histogram -0.0484
Fundamentals Value
Market Cap 3.43 Billion
Num Shares 365 Million
EPS -2.65
Price-to-Earnings (P/E) Ratio -3.54
Price-to-Sales 0.35
Price-to-Book 18.78
PEG Ratio 0.63
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.72
Resistance 3 (R3) 9.68 9.53 9.66
Resistance 2 (R2) 9.53 9.45 9.55 9.64
Resistance 1 (R1) 9.46 9.39 9.50 9.49 9.62
Pivot Point 9.31 9.31 9.33 9.33 9.31
Support 1 (S1) 9.23 9.22 9.27 9.27 9.14
Support 2 (S2) 9.08 9.17 9.10 9.12
Support 3 (S3) 9.01 9.08 9.10
Support 4 (S4) 9.04